Effects of platelet concentrate storage time reduction in patients after blood stem cell transplantation

被引:10
作者
Heuft, H. -G. [1 ]
Goudeva, L. [1 ]
Krauter, J. [2 ]
Peest, D. [2 ]
Buchholz, S. [2 ]
Tiede, A. [2 ]
机构
[1] Hannover Med Sch, Inst Transfus Med, D-30625 Hannover, Germany
[2] Hannover Med Sch, Dept Hematol Oncol Hemostasis & Stem Cell Transpl, D-30625 Hannover, Germany
关键词
platelet concentrates; platelet transfusion; platelet storage time; ADDITIVE SOLUTION; BACTERIAL-CONTAMINATION; THERAPEUTIC-EFFICACY; BUFFY-COAT; TRANSFUSION; APHERESIS; PLASMA; SINGLE; MULTICENTER; INCREMENTS;
D O I
10.1111/vox.12015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To evaluate the clinical effect of platelet concentrate (PC) transfusions after PC storage time reduction to 4days. Patients and Methods This was a single-centre cohort study comparing two 3-month periods of time, before and after the reduction of PC storage time from 5 to 4days. Seventy-seven consecutive patients with PC transfusions were enrolled after blood stem cell transplantation. Corrected platelet count increment (CCI) on the morning after transfusion, time to next platelet transfusion, need for red blood cell (RBC) transfusion and clinical bleeding symptoms were compared. Results Platelet concentrate storage time was reduced between period 1 (storage for up to 5days, median storage time 78h, range 11-136h) and period 2 (storage for up to 4days, median storage time 53h, range 11-112h). Patients were comparable for age, weight, body surface area, underlying disorder, type of transplantation and transfused platelet dose. The CCI increased from a median of 4 (range 0-20) to 8 (0-68)x109/l per 1011 platelets/m2 (P<0 center dot 0001). Time to next PC transfusion increased from 1 center dot 1 to 2 center dot 0days (P<0 center dot 0001). Any bleeding symptom was noted in 20 of 36 patients (56%) vs. 9/41 patients (22%, P<0 center dot 01). Nose bleeds, haematuria and bleeding at more than one site were significantly reduced. Frequency of RBC transfusion within 5days after PC transfusion was reduced from 74 to 58% (P<0 center dot 0001). Conclusion Platelet concentrate storage time shortening was associated with highly significant CCI increase, reduced RC needs and lower patient numbers with bleeding events.
引用
收藏
页码:18 / 27
页数:10
相关论文
共 50 条
  • [41] Comparison of transfusion requirements in adult patients undergoing Haploidentical or single-unit umbilical cord blood stem cell transplantation
    Solves, Pilar
    Sanz, Jaime
    Gomez, Ines
    de la Puerta, Rosalia
    Arnao, Mario
    Montoro, Juan
    Luis Pinana, Jose
    Carretero, Carlos
    Balaguer, Aitana
    Guerreiro, Manuel
    Andreu, Rafa
    Rodriguez, Rebeca
    Montesinos, Pau
    Jarque, Isidro
    Ignacio Lorenzo, Jose
    Carpio, Nelly
    Angel Sanz, Miguel
    Francisco Sanz, Guillermo
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2019, 103 (03) : 172 - 177
  • [42] Pharmacotherapy for the Prevention of Depression and Behavioral Side Effects in Hematopoietic Stem Cell Transplantation Patients
    Mumby, Patricia
    Adams, William
    Smith, Scott
    Rao, Murali
    Stiff, Patrick
    TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (03): : 320.e1 - 320.e11
  • [43] The assessment of platelet function by thromboelastometry as a point-of-care test to guide Intercept-treated platelet support in hemato-oncological patients and hematopoietic stem cell transplantation recipients
    Leitner, Gerda C.
    Ho, Markus
    Tolios, Alexander
    Hopfinger, Georg
    Rabitsch, Werner
    Wohlfarth, Philipp
    TRANSFUSION, 2020, 60 (07) : 1391 - 1399
  • [44] Factors associated with response to platelet transfusion following hematopoietic stem cell transplantation
    Klumpp, TR
    Herman, JH
    Innis, S
    Pearlman, E
    Culling, N
    Kotz, KW
    Slachta, C
    Goldberg, SL
    Mangan, KF
    BONE MARROW TRANSPLANTATION, 1996, 17 (06) : 1035 - 1041
  • [45] A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation
    Crighton, Gemma L.
    Estcourt, Lise J.
    Wood, Erica M.
    Trivella, Marialena
    Doree, Carolyn
    Stanworth, Simon
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (09):
  • [46] Factors influencing post-transfusional platelet increment in pediatric patients given hematopoietic stem cell transplantation
    Balduini, CL
    Salvanesch, L
    Klersy, C
    Noris, P
    Mazzucco, M
    Rizzuto, F
    Giorgiani, G
    Perotti, C
    Stroppa, P
    Di Pumpo, M
    Nobili, B
    Locatelli, F
    LEUKEMIA, 2001, 15 (12) : 1885 - 1891
  • [47] Comparison of six different specimen types for Epstein-Barr viral load quantification in peripheral blood of pediatric patients after heart transplantation or after allogeneic hematopoietic stem cell transplantation
    Ruf, S.
    Behnke-Hall, K.
    Gruhn, B.
    Bauer, J.
    Horn, M.
    Beck, J.
    Reiter, A.
    Wagner, H. J.
    JOURNAL OF CLINICAL VIROLOGY, 2012, 53 (03) : 186 - 194
  • [48] Red cell and platelet transfusion burden following myeloablative allogeneic haemopoietic stem cell transplantation
    Le Viellez, A.
    P'Ng, S.
    Buffery, S.
    Wright, M.
    Cooney, J.
    Cannell, P.
    Purtill, D.
    INTERNAL MEDICINE JOURNAL, 2015, 45 (12) : 1286 - 1292
  • [49] Virome definition in cerebrospinal fluid of patients with neurological complications after hematopoietic stem cell transplantation
    Pau, C.
    Barrientos-Somarribas, M.
    Marin-Juan, S.
    Bogdanovic, G.
    Bjerkner, A.
    Allander, T.
    Gustafsson, B.
    Andersson, B.
    JOURNAL OF CLINICAL VIROLOGY, 2018, 108 : 112 - 120
  • [50] Intensity of endogenous thrombocytopenia after autologous stem cell transplantation in patients prophylactically transfused with platelets
    Voss, Andreas
    Doescher, Andrea
    Kapels, Hans-Hermann
    Seltsam, Axel
    Greinacher, Andreas
    Metzner, Bernd
    Mueller, Thomas H.
    VOX SANGUINIS, 2023, 118 (07) : 559 - 566